Using two different breast cancer cell lines, the authors established that miR-224-3p, through the downregulation of the FUT4 gene, is capable of reverting the MDR phenotype and of increasing sensitivity to taxol, vincristine, and doxorubicin (12). The gene discussed is FUT4; the disease is breast cancer.